Bo Albinsson
Handledare vid Institutionen för medicinska vetenskaper; Grundutbildning
- Telefon:
- 018-611 96 15
- E-post:
- bo.albinsson@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, Ingång 40, 5 tr
751 85 UPPSALA
Doktorand vid Institutionen för medicinsk biokemi och mikrobiologi; Infektioner och Immunitet; Åke Lundkvist
- E-post:
- bo.albinsson@imbim.uu.se
- Besöksadress:
- BMC
Husargatan 3
752 37 UPPSALA - Postadress:
- Box 582
751 23 UPPSALA
- ORCID:
- 0000-0002-1184-9267
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Publikationer
Senaste publikationer
- Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019 (2024)
- Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms (2022)
- A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients (2022)
- Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2 (2021)
- Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients (2021)
Alla publikationer
Artiklar
- Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019 (2024)
- Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms (2022)
- A third dose SARS-CoV-2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients (2022)
- Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2 (2021)
- Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients (2021)
- Multi laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017 (2020)
- Distinction between serological responses following tick-borne encephalitis virus (TBEV) infection vs vaccination, Sweden 2017 (2018)
